SmallCaps
ASX:RADPharmaceuticals, Biotechnology & Life SciencesBiotechnology

RADIOPHARM THERANOSTICS ORD

$0.020
$0.002 (9.09%)
Day Range
$0.020 - $0.021
52 Week Range
$0.017 - $0.040
Volume
1.25M
Avg Volume (10D)
3.10M
Market Cap
$70.88M
Price Chart
Market Statistics
Open$0.021
Previous Close$0.022
Day High$0.021
Day Low$0.020
52 Week High$0.040
52 Week Low$0.017
Valuation
Market Cap70.88M
Shares Outstanding3.54B
Price to Book1.51
Trading Activity
Volume1.25M
Value Traded25.99K
Bid$0.020 × 1,002,021
Ask$0.022 × 2,146,575
Performance
1 Day4.76%
5 Day4.76%
13 Week-12.00%
52 Week-26.67%
YTD-12.00%
Technical Indicators
RSI (14)40.83
50-Day SMA$0.022
200-Day SMA$0.025
Latest News
Radiopharm Theranostics advances cancer treatment with RAD 301 and RAD 302 developments
Biotechnology

Radiopharm Theranostics advances cancer treatment with RAD 301 and RAD 302 developments

Radiopharm Theranostics (ASX: RAD) has welcomed the release of new data identifying a promising pathway for its innovative RAD 301 and RAD 302 oncology developments. Multiple new data covering the RAD 301 and RAD 302 programs were featured at the 2024 European Molecular Imaging Meeting (EMIM) in Portugal this week. RAD 302, which is currently […]

3 min read
Colin Hay
Colin Hay